PL1829874T3 - Tricykliczny związek i jego zastosowanie - Google Patents

Tricykliczny związek i jego zastosowanie

Info

Publication number
PL1829874T3
PL1829874T3 PL05820106T PL05820106T PL1829874T3 PL 1829874 T3 PL1829874 T3 PL 1829874T3 PL 05820106 T PL05820106 T PL 05820106T PL 05820106 T PL05820106 T PL 05820106T PL 1829874 T3 PL1829874 T3 PL 1829874T3
Authority
PL
Poland
Prior art keywords
tricyclic compound
tricyclic
compound
Prior art date
Application number
PL05820106T
Other languages
English (en)
Inventor
Junichiro Manako
Yoshifumi Kagamiishi
Masashi Kato
Kazuyuki Ohmoto
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of PL1829874T3 publication Critical patent/PL1829874T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL05820106T 2004-12-22 2005-12-21 Tricykliczny związek i jego zastosowanie PL1829874T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2004371033 2004-12-22
JP2005261914 2005-09-09
EP20050820106 EP1829874B1 (en) 2004-12-22 2005-12-21 Tricyclic compound and use thereof
PCT/JP2005/023450 WO2006068164A1 (ja) 2004-12-22 2005-12-21 三環式化合物およびその用途

Publications (1)

Publication Number Publication Date
PL1829874T3 true PL1829874T3 (pl) 2014-07-31

Family

ID=36601763

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05820106T PL1829874T3 (pl) 2004-12-22 2005-12-21 Tricykliczny związek i jego zastosowanie

Country Status (8)

Country Link
US (4) US7964726B2 (pl)
EP (1) EP1829874B1 (pl)
JP (2) JP4997976B2 (pl)
DK (1) DK1829874T3 (pl)
ES (1) ES2459742T3 (pl)
PL (1) PL1829874T3 (pl)
PT (1) PT1829874E (pl)
WO (1) WO2006068164A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7872133B2 (en) * 2003-06-23 2011-01-18 Ono Pharmaceutical Co., Ltd. Tricyclic heterocycle compound
WO2006068164A1 (ja) * 2004-12-22 2006-06-29 Ono Pharmaceutical Co., Ltd. 三環式化合物およびその用途
DE102006033114A1 (de) 2006-07-18 2008-01-24 Grünenthal GmbH Spirocyclische Azaindol-Derivate
JOP20180077A1 (ar) 2007-06-19 2019-01-30 Kythera Biopharmaceuticals Inc تركيبات وطرق لحمض صفراوي تخليقي
US20080318870A1 (en) 2007-06-19 2008-12-25 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
US8242294B2 (en) 2007-06-19 2012-08-14 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
SG186826A1 (en) * 2010-07-06 2013-02-28 Ono Pharmaceutical Co Tetrahydrocarboline derivative
TW201625244A (zh) * 2014-06-12 2016-07-16 小野藥品工業股份有限公司 壓力性疾病之預防及／或治療用醫藥
US9907786B2 (en) 2014-10-21 2018-03-06 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof
US10092550B2 (en) 2014-10-21 2018-10-09 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof
WO2016111357A1 (ja) * 2015-01-09 2016-07-14 小野薬品工業株式会社 線維筋痛症の予防および／または治療剤
US10033334B1 (en) 2017-03-23 2018-07-24 Globalfoundries Inc. Peaking amplifier frequency tuning
US9853612B1 (en) 2017-03-23 2017-12-26 Globalfoundries Inc. Peaking amplifier frequency tuning
EP4267578A1 (en) 2020-12-23 2023-11-01 Recurium IP Holdings, LLC Estrogen receptor modulators

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1431702A (fr) 1964-11-23 1966-03-18 Sames Mach Electrostat Perfectionnements à l'élaboration des échantillons ou étalons utilisés en analyse radiochimique
SU788471A1 (ru) 1972-11-28 1981-12-30 Всесоюзный Научно-Исследовательский Химико-Фармацевтический Институт Им.С.Орджоникидзе Психотропное средство дл лечени депрессивных состо ний "инказан
US3959470A (en) * 1972-11-28 1976-05-25 Mikhail Davidovich Mashkovsky Psychotropic medicinal preparation
US4336260A (en) * 1977-12-08 1982-06-22 The Dow Chemical Company Method and compositions using 1-aryl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid for treating depression
EP0357122A3 (en) * 1988-08-29 1991-10-23 Duphar International Research B.V Use of beta-carbolines, their bio-isosteric benzofuran and benzothiophene analogues for the manufacture of a medicament having cytostatic properties
JPH03287586A (ja) 1990-04-02 1991-12-18 Taisho Pharmaceut Co Ltd テトラヒドロ―β―カルボリン誘導体
GB9401090D0 (en) 1994-01-21 1994-03-16 Glaxo Lab Sa Chemical compounds
US5403851A (en) * 1994-04-05 1995-04-04 Interneuron Pharmaceuticals, Inc. Substituted tryptamines, phenalkylamines and related compounds
FR2724384B1 (fr) * 1994-09-14 1999-04-16 Cemaf Nouveaux derives de la 3,4-dihydro beta-carboline agonistes de la melatonine, leur procede de preparation et leur utilisation a titre de medicament
YU49898A (sh) 1996-05-10 2000-03-21 Icos Corporation Hemijska jedinjenja
ES2172006T3 (es) * 1996-10-21 2002-09-16 Eurovita As Composiciones farmaceuticas que contienen parthenium integrifolium o partes de la misma o un extracto o componente de la misma, uso de dicho material de planta para la preparacion de ciertos medicamentos y procedimiento de preparacion de un extracto de parthenium integrifolium.
DE19712201A1 (de) 1997-03-24 1998-10-01 Bodenseewerk Geraetetech Mikromechanische Spiegel-Anordnung
US6043252A (en) * 1997-05-05 2000-03-28 Icos Corporation Carboline derivatives
CA2335339A1 (en) * 1998-06-12 1999-12-16 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R .beta.-carboline compounds
AU1025899A (en) * 1998-09-16 2000-04-03 Icos Corporation Carboline derivatives as cgmp phosphodiesterase inhibitors
FR2796644B1 (fr) 1999-07-23 2001-09-07 Adir Nouveaux derives de beta-carboline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
UA74826C2 (en) * 2000-05-17 2006-02-15 Ortho Mcneil Pharm Inc ?-carboline derivatives as phosphodiesterase inhibitors
US7488742B2 (en) * 2000-06-15 2009-02-10 Schering Corporation Thrombin receptor antagonists
AU2001266575A1 (en) * 2000-06-26 2002-01-08 Lilly Icos Llc Chemical compounds
EP1832590B8 (en) * 2000-12-28 2012-04-25 Ono Pharmaceutical Co., Ltd. Heterotricyclic compounds as CRF receptor antagonists
WO2002064590A2 (en) 2001-02-12 2002-08-22 Lilly Icos Llc Carboline derivatives
JP4223285B2 (ja) * 2001-02-12 2009-02-12 リリー アイコス リミテッド ライアビリティ カンパニー 化合物
GB0108337D0 (en) * 2001-04-03 2001-05-23 Novartis Ag Organic compounds
US7115621B2 (en) * 2001-04-25 2006-10-03 Lilly Icos Llc Chemical compounds
JPWO2003030937A1 (ja) 2001-10-05 2005-01-20 小野薬品工業株式会社 ミトコンドリアルベンゾジアゼピン受容体アンタゴニストからなるストレス疾患の治療剤
SE520453C2 (sv) * 2001-11-01 2003-07-15 Alfa Laval Corp Ab En apparat för samtidig rening av en vätska och en gas
TW200305423A (en) 2002-02-14 2003-11-01 Ono Pharmaceutical Co N-carbamoyl nitrogen-containing condensed ring compound and medicament containing same as active ingredient
TWI329111B (en) 2002-05-24 2010-08-21 X Ceptor Therapeutics Inc Azepinoindole and pyridoindole derivatives as pharmaceutical agents
US7872133B2 (en) * 2003-06-23 2011-01-18 Ono Pharmaceutical Co., Ltd. Tricyclic heterocycle compound
AU2005206570A1 (en) 2004-01-23 2005-08-04 Novartis Vaccines And Diagnostics, Inc. Tetrahydrocarboline compounds as anticancer agents
SG184755A1 (en) 2004-03-15 2012-10-30 Ptc Therapeutics Inc Carboline derivatives useful in the inhibition of angiogenesis
US7403851B2 (en) * 2004-09-30 2008-07-22 Navteq North America, Llc Method of operating a navigation system to report effects of updated portions of a geographic database
WO2006068164A1 (ja) * 2004-12-22 2006-06-29 Ono Pharmaceutical Co., Ltd. 三環式化合物およびその用途

Also Published As

Publication number Publication date
ES2459742T3 (es) 2014-05-12
US20080114012A1 (en) 2008-05-15
EP1829874A1 (en) 2007-09-05
US20110207700A1 (en) 2011-08-25
US20150105415A1 (en) 2015-04-16
US8952158B2 (en) 2015-02-10
EP1829874B1 (en) 2014-02-12
JP4997976B2 (ja) 2012-08-15
EP1829874A4 (en) 2010-01-06
US8476293B2 (en) 2013-07-02
PT1829874E (pt) 2014-04-10
DK1829874T3 (da) 2014-05-12
JP2012126737A (ja) 2012-07-05
JP5652417B2 (ja) 2015-01-14
US7964726B2 (en) 2011-06-21
JPWO2006068164A1 (ja) 2008-06-12
US20130252993A1 (en) 2013-09-26
WO2006068164A1 (ja) 2006-06-29

Similar Documents

Publication Publication Date Title
PT1829874E (pt) Composto tricíclico e sua utilização
EP1790639A4 (en) A BASIC GROUP CONNECTING AND APPLYING THEREOF
EP1802588A4 (en) SUBSTITUTED AMINOPYRIMIDONE AND APPLICATIONS THEREOF
IL181670A0 (en) Substituted phenylaminothiazoles and use thereof
EP1778214A4 (en) NEW BIPHENYL COMPOUNDS AND THEIR USE
EP1755392A4 (en) ISOFLAVONOID COMPOSITIONS AND ITS USE
IL179497A0 (en) Carboranylporphyrins and uses thereof
PL2215908T3 (pl) 2-alkilo-cykloalk(en)ylo-karboksamidy i ich zastosowanie jako fungicydów
EP1921066A4 (en) PYRIDYLPHENOL COMPOUND AND USE THEREOF
IL180365A0 (en) Carboranylporphyrins and uses thereof
ZA200609075B (en) Isoflavonoid compounds and use thereof
EP1810976A4 (en) BENZONAPHTHACENEGLYCOSIDE DERIVATIVE AND THE USE THEREOF
ZA200705455B (en) Silicon compounds and their use
GB0407628D0 (en) Compounds and their use
GB0409378D0 (en) Compounds and their use
GB0423234D0 (en) Compounds and their use
GB0411071D0 (en) Compounds and their use
GB0409377D0 (en) Compounds and their use
GB0409379D0 (en) Compounds and their use
GB0401244D0 (en) Compounds and their use
GB0410833D0 (en) Compounds and their use
GB0410832D0 (en) Compounds and their use
GB0410831D0 (en) Compounds and their use
GB0402903D0 (en) Compounds and their use
GB0410830D0 (en) Compounds and their use